A prospective, multicenter, open-label phase III study of emicizumab prophylaxis in patients with acquired hemophilia A

Authors :: Midori Shima
Kagehiro Amano
Yoshiyuki Ogawa
Koichiro Yoneyama
Ryoto Ozaki
Ryota Kobayashi
Emiko Sakaida
Makoto Saito
Takashi Okamura
Toshihiro Ito
Norimichi Hattori
Satoshi Higasa
Nobuaki Suzuki
Yoshinobu Seki
Keiji Nogami
Source :: Journal of Thrombosis and Haemostasis. 21:534-545
Publication Year :: 2023
Publisher :: Elsevier BV, 2023.

Tools